Cooperative Agreement UH3DE032208
Award Date
9/17/24
Completion Date
8/31/26
Dollars Obligated
$587K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Cooperative Agreement
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
This $1,657,610 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will support a project at Thomas Jefferson University to utilize single cell RNA sequencing to identify and classify cell populations and gene expression in temporomandibular joint (TMJ) synovial fluid. The project aims to determine if synovial fluid from symptomatic TMJ disorder (TMJD) patients contains a unique cell...
This $222,500 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research at The Children's Hospital of Philadelphia (CHOP) to investigate the pathogenic mechanisms of temporomandibular joint (TMJ) osteophyte formation. The key objectives are to test whether conditional ablation of the gene EXT1, which is involved in heparan sulfate synthesis, causes osteophyte formation...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $1,488,960.00 to the University of Southern California to conduct research on the role of LGR+ connective tissue progenitors in temporomandibular joint (TMJ) development. The key objectives are to: 1) perform lineage tracing to test if LGR4 and LGR5 in mice, and LGR4 and LGR6 in zebrafish, mark connective tissue stem...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) will support research to understand the mechanisms of nociplastic pain, a form of chronic pain, in patients with temporomandibular disorders (TMD). The $1,831,197 award to Emory University will enable the researchers to: Use standardized quantitative sensory testing (QST) procedures to assess nociplastic pain, sensory...
This $603,502 Cooperative Agreement award from the National Institute of Dental and Craniofacial Research (CFDA 93.121 - Oral Diseases and Disorders Research) will fund a clinical trial evaluating the safety and analgesic efficacy of a marine oil supplement containing specialized pro-resolving mediators in adults with chronic temporomandibular pain. The study aims to quantify the effects of the intervention on pain intensity, hyperalgesia, psychological distress, sleep disturbance, and...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $1,013,625.00 to the University of Pittsburgh to support research on developing a safe and effective temporomandibular joint (TMJ) disc replacement. The goal is to address the lack of FDA-approved TMJ disc replacements, which often leads to joint problems in patients who have the natural disc surgically removed....
This federal Project Grant award of $143,285 from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) aims to investigate the cellular origins of jaw joint cartilage regeneration in zebrafish. The project will optimize a transgenic zebrafish model to ablate and then track the regeneration of jaw joint cartilage, focusing on three potential sources of regenerating chondrocytes: the perichondrium, deeper...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant under its Biomedical Research and Research Training program (CFDA 93.859) to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division, to support research on targeting senescent cells for alleviating temporomandibular joint (TMJ) degeneration. The $350,000 grant, awarded on September 5, 2024, aims to define the role of p21-positive senescent cells in...
This Project Grant award, with an ID of R01DE032676, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,372,115 award, spanning from July 2024 to June 2027, supports research to identify and validate the lysophosphatidic acid (LPA)/LPA receptor (LPAR) signaling pathway as a novel target for the treatment of temporomandibular disorder (TMD) pain. The primary research objectives are to: 1)...
This National Institute of Dental and Craniofacial Research (NIDCR) Project Grant award under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $320,053 to the University of Southern California (USC) to conduct comprehensive research on the craniofacial skeleton and connective tissue development. The 8-year project will utilize advanced techniques in spatial transcriptomics and mouse genetics to identify genes and pathways regulating the assembly of the craniofacial...